Registered Kenya · PPB

NEFEXIM 100 DRY SYRUP

CEFEXIME FOR ORAL SUSPENSION

H2016/CTD3708/465 100 MG NEW/INNOVATOR

What it does

Cefexime is an antibiotic that helps fight bacterial infections in the body.

Commonly used for: bacterial infections, chest infections (pneumonia), ear infections (otitis media), throat infections (pharyngitis) …

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Hard to find? We help patients in Kenya source rare medicines. We don't sell or dispense medicines - licensed pharmacies do.

Source this medicine

Registration & product details

Registration no.
H2016/CTD3708/465
Registration date
-
Expiry date
-
Status
Registered
Active ingredient
CEFEXIME FOR ORAL SUSPENSION
Dosage form
100 MG
Strength
-
Pack size
1 BOTTLE
Therapeutic class
NEW/INNOVATOR
Manufacturer / MAH
Nairobi Enterprises
Country of origin
FOREIGN
Manufacturer location
JWW2+25R, Old Mombasa Rd, Nairobi. Shiv business park, Opposite SGR Nairobi terminus-old Mombasa road , Warehouse NO-15, Nairobi, Kenya

Source: Pharmacy and Poisons Board · fetched 2026-01-28 20:32:39 · updated 2026-07-26 11:23:21

Disclaimer: This information is sourced from Pharmacy and Poisons Board (Kenya). Always consult a qualified healthcare professional before using any medication.

About this medicine

Cefexime is an antibiotic that helps fight bacterial infections in the body.

What it treats

  • bacterial infections
  • chest infections (pneumonia)
  • ear infections (otitis media)
  • throat infections (pharyngitis)
  • urinary tract infections

How it works

It works by stopping the growth of bacteria, helping to eliminate the infection.

Who it's for

Cefexime is for adults and children who need treatment for certain bacterial infections.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: cefexime

Cefixime is a third-generation cephalosporin antibiotic that is used to treat a variety of bacterial infections. It is effective against both Gram-positive and Gram-negative bacteria, making it a broad-spectrum antimicrobial agent. Cefixime is often prescribed for infections such as otitis media, pharyngitis, and urinary tract infections. It is administered orally and has good bioavailability, allowing for convenient dosing regimens.

Indications

  • Urinary tract infections
  • Otitis media
  • Pharyngitis
  • Gonorrhea
  • Bronchitis

Dosage

Children: Refer to the BNF for Children for appropriate dosing information based on the child's age and weight.

Adults: Refer to the BNF for specific dosing guidelines based on the type and severity of infection.

Mechanism of action

Cefixime works by inhibiting bacterial cell wall synthesis. It binds to penicillin-binding proteins (PBPs) located inside the bacterial cell wall, disrupting the cross-linking of peptidoglycan layers. This leads to the weakening of the cell wall, resulting in cell lysis and death of the bacteria. Cefixime is particularly effective against organisms that produce beta-lactamases, which can inactivate other antibiotics.

Pharmacodynamics

Cefixime exhibits time-dependent bactericidal activity. Its efficacy is influenced by the duration of time that the drug concentration remains above the minimum inhibitory concentration (MIC) for the target organism. The drug is generally well tolerated, with a side effect profile that includes gastrointestinal disturbances, allergic reactions, and potential changes in blood parameters. It displays a wide spectrum of activity against Streptococcus pneumoniae, Haemophilus influenzae, and Escherichia coli.

Pharmacokinetics

After oral administration, cefixime is well absorbed from the gastrointestinal tract, with peak plasma concentrations occurring approximately 2 to 6 hours post-dose. It has a bioavailability of around 40-50%. Cefixime is widely distributed throughout the body, including the lungs, kidneys, and biliary tract. The drug is primarily excreted unchanged in the urine, with a half-life of approximately 3 to 4 hours. Renal impairment may necessitate dosage adjustments.

Contra-indications

  • Hypersensitivity to cefixime or any component of the formulation
  • Previous severe allergic reaction to penicillins or other cephalosporins

Adverse effects

  • Diarrhea
  • Nausea
  • Vomiting
  • Abdominal pain
  • Rash
  • Urticaria
  • Elevated liver enzymes
  • Renal impairment
  • Anaphylaxis (rare)
  • Clostridium difficile-associated diarrhea

Interactions

  • Antacids may reduce absorption of cefixime
  • Probenecid may increase the serum concentration of cefixime
  • Cefixime may enhance the effects of anticoagulants

Precautions

  • Use with caution in patients with a history of gastrointestinal disease, particularly colitis
  • Monitor renal function in patients with renal impairment
  • Caution in patients with known allergies to beta-lactam antibiotics

Pregnancy

Cefixime is classified as Category B. Animal studies have not demonstrated a risk to the fetus, but there are no adequate and well-controlled studies in pregnant women. Use only if clearly needed.

Breast-feeding

Cefixime is excreted in breast milk. Caution should be exercised when administering to nursing mothers.

Storage

Store at room temperature, away from moisture and heat. Keep out of reach of children.

Formulations

  • Cefixime 200 mg tablets
  • Cefixime 400 mg tablets
  • Cefixime 100 mg/5 mL oral suspension

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.